Fact CheckerSign in

NCT06484478Completed

A Real-world Wearables Study in Fabry Disease.

A Real-world Monitoring Project Exploring Day-to-day Physical Activity, Sleep, and Quality of Life in Individuals With Fabry Disease.

Source: ClinicalTrials.gov · Last updated 16 Mar 2026

Brief summary (registry, in English)

Despite improvements in Fabry disease care in recent years, many patients still have poor outcomes. In addition to the many physical symptoms that patients can experience, the disease also places individuals at an increased risk of mental health conditions, such as anxiety and depression. Low physical activity levels and increased sedentary time are detrimentally associated with anxiety, depression and quality of life in the general population. Currently, no such research has been conducted in individuals with Fabry disease. Data will consist of: (1) information from hospital medical records, (2) patient reported outcomes collected via questionnaires, and (3) measurements from a clinical-grade wearable device. Individuals with Fabry disease aged 18 years or above will be considered for eligibility screening.

Status (registry)
Completed
Study type
Observational
Enrollment
100 (actual)
First submitted
12 Jun 2024
Start date
5 Nov 2024
Primary completion date
29 May 2025
Lead sponsor
Royal Free Hospital NHS Foundation Trust
NCT number
NCT06484478

What you commit to

  • Study type: Observational
  • Participants enrolled: 100
  • From 5 Nov 2024 to the primary completion date, 29 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • A known allergy to any materials in the wearable device.

Other

  • Not able to have or use a wearable.
  • Taking part in an interventional study which would preclude real-world data collection.
  • Unable to communicate in English to a sufficient level to permit engagement in the study.

Who the study is looking for

  • Diagnosis of Fabry disease documented by genotyping and/or enzymatic analysis.
  • Resident in the UK.
  • Aged 18 years and over.
  • Capable of providing informed consent.
  • Physically able to stand and ambulate independently.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Royal Free London NHS Foundation Trust
Coordinator of this site? Confirm its status
LondonUnited KingdomUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.